Loraz and Humulin n drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Humulin n (insulin susp isophane recombinant human). Common drug interactions include infection among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Humulin n. It is created by eHealthMe based on reports of 85 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Humulin n?

Humulin n has active ingredients of insulin susp isophane recombinant human. It is often used in diabetes. eHealthMe is studying from 9,878 Humulin n users. Check the latest studies of Humulin n.



On Jul, 10, 2026

85 people who take Loraz and Humulin n together, and have interactions are studied.

Loraz and Humulin n drug interactions.

What are the common drug interactions of Loraz and Humulin N, by gender? *:

female:

  1. Infection
  2. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  3. Dyspnoea (difficult or laboured respiration)
  4. Nausea (feeling of having an urge to vomit)
  5. Renal injury (kidney injury)
  6. Blood glucose increased
  7. Dysgeusia (disorder of the sense of taste)
  8. Gait disturbance
  9. General physical health deterioration (weak health status)
  10. Lower limb fracture

male:

  1. Headache (pain in head)
  2. Pain
  3. Agitation (state of anxiety or nervous excitement)
  4. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  5. Cellulitis (infection under the skin)
  6. Cholecystitis (infection of gallbladder)
  7. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  8. Confusional state
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Depressed level of consciousness

What are the common drug interactions of Loraz and Humulin N, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

30-39:

  1. Dyspnoea (difficult or laboured respiration)
  2. Infection
  3. Lower respiratory tract infection
  4. Malaise (a feeling of general discomfort or uneasiness)

40-49:

  1. Hyperhidrosis (abnormally increased sweating)
  2. Nausea (feeling of having an urge to vomit)
  3. Drug ineffective
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Vomiting
  6. Abdominal pain
  7. Agitation (state of anxiety or nervous excitement)
  8. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  9. Cellulitis (infection under the skin)
  10. Cholecystitis (infection of gallbladder)

50-59:

  1. Cardiac disorder
  2. Chest pain
  3. Dizziness
  4. Dyspnoea (difficult or laboured respiration)
  5. Groin infection (infection in groin)
  6. Infusion related reaction
  7. Migraine (headache)
  8. Pain
  9. Renal disorder (kidney disease)
  10. Arthralgia (joint pain)

60+:

  1. Fatigue (feeling of tiredness)
  2. Hypoglycaemia (deficiency of glucose in the bloodstream)
  3. Dizziness
  4. Nausea (feeling of having an urge to vomit)
  5. Generalised oedema (swelling all over the body)
  6. Glycosylated haemoglobin increased
  7. Gravitational oedema (abnormally large fluid volume in the circulatory system makes obese)
  8. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
  9. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 11 people, 12.94%
  2. Type 2 Diabetes: 10 people, 11.76%
  3. Pain: 7 people, 8.24%
  4. High Blood Pressure: 7 people, 8.24%
  5. High Blood Cholesterol: 7 people, 8.24%
  6. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 6 people, 7.06%
  7. Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Humulin n?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Loraz and Humulin n:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Humulin n:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Loraz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Humulin n and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and insulin susp isophane recombinant human (the active ingredients of Loraz and Humulin n, respectively), and Loraz and Humulin n (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: